GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 14 filers reported holding GENETIC TECHNOLOGIES LTD in Q3 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 655 | +210.4% | 0.00% | – |
| Q1 2023 | $0 | – | 211 | -53.8% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 457 | -74.4% | 0.00% | – |
| Q1 2022 | $3,000 | -86.4% | 1,784 | -84.9% | 0.00% | – |
| Q4 2021 | $22,000 | -79.4% | 11,826 | -52.9% | 0.00% | – |
| Q3 2021 | $107,000 | +0.9% | 25,096 | -0.2% | 0.00% | – |
| Q2 2021 | $106,000 | -5.4% | 25,158 | -6.6% | 0.00% | – |
| Q1 2021 | $112,000 | +75.0% | 26,930 | +50.7% | 0.00% | – |
| Q4 2020 | $64,000 | +255.6% | 17,865 | +238.0% | 0.00% | – |
| Q3 2020 | $18,000 | – | 5,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scarborough Advisors, LLC | 10,638 | $8,838 | 0.00% |
| Virtu Financial LLC | 18,182 | $15 | 0.00% |
| Gradient Investments LLC | 2,192 | $1,821 | 0.00% |
| NewSquare Capital LLC | 100 | $83 | 0.00% |
| UBS Group AG | 100 | $83 | 0.00% |
| RHUMBLINE ADVISERS | 18,700 | $15,633 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $831 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 88,356 | $73,406 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,906 | $12,384 | 0.00% |